The Freespira® breathing system helps patients with panic disorder reduce the severity of their panic attacks.
Real benefits for clinicians
“Freespira® helped patients reduce panic symptoms and panic attacks, leading to a better quality of life and overall reduced costs.”
Anthony P. Mannarino – Clinical Lead
PhD, Professor and Vice Chair, Department of Psychiatry, Allegheny General Hospital
overall medical costs reduction PMPM (12 months post-treatment)1
overall pharmacy cost reduction PMPM (12 months post-treatment)1
ER cost reduction PMPM (12 months post-treatment)1
Value for technology leaders
“Improving health outcomes for the patient and reducing overall medical costs is a win-win-win for the patient, provider, and insurer. The goal of the VITAL program is to accelerate reimbursement by Highmark Health for novel solutions that would normally take several years to receive coverage and payment.”
Debra Reisenthel – CEO Palo Alto Health Sciences, Inc.
California-based manufacturer of Freespira®
A VITAL collaboration
Thanks to VITAL’s collaboration with Palo Alto Health Sciences, Inc. and Allegheny Health Network physicians, patients who experience frequent panic attacks may soon have access to a new drug-free treatment.
The Freespira® in-home digital therapeutic device treats the physiological component of panic attacks that occur in patients who suffer from anxiety. It uses a sensor to control chronic hyperventilation by training the body to normalize its CO2 levels and breathing rate.
For the participants enrolled in the testing of Freespira®, it eliminated or reduced panic attacks and other panic symptoms for at least 12 months post-treatment1.
Successful collaboration led to changes to medical policy as of May 2018.